Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients
- PMID: 29222436
- PMCID: PMC5722863
- DOI: 10.1038/s41533-017-0064-4
Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients
Abstract
The "Asthma Control Questionnaire" (ACQ) is a very common questionnaire for assessing asthma control. This study compares different ACQ versions in a self-monitoring program over a 12-week period combining them with patients' self-measurements of peak expiratory flow (PEF) and forced expiratory volume in one second (FEV1). The objective was to test the feasibility of FEV1-self-measurements and to compare ACQ versions regarding possible additional information given by lung function. In this prospective multicenter observational study 100 adult asthma patients, recruited at six family practices and two pulmologists' private practices in Germany, completed the ACQ weekly, performing self-measurements of PEF and FEV1. Seventy-six patients were included into final analysis with only 3% missing values. Scores for all ACQ versions improved significantly (all P-values < 0.05) with reductions of 32% for ACQ5, 31% for ACQ6, 22% for ACQ7-FEV1, and 21% for ACQ7-PEF with high Pearson's correlation coefficients of all scores (r between 0.96 and 0.99). ACQ7-FEV1 scores were significantly higher than others. Separated courses of lung function parameters showed nearly no change, but ACQ5 and ACQ6 as scores for symptoms and reliever medication improved constantly. ACQ5 and ACQ6 revealed higher percentages of patients classified as "controlled" than ACQ7-scores. In conclusion, with only a few missing data points, our results suggest feasibility of FEV1-self-measurements. Courses of symptom-related and lung function-related ACQ items differ clearly. Our results support the GINA recommendations to consider symptoms and lung function separately. FEV1-self-measurements for research purposes may be included with the ACQ, but in clinical practice seem to measure a different domain to symptomatic asthma control.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
[Assessment of the simplified versions of the Asthma Control Questionnaire].Med Clin (Barc). 2008 Sep 20;131(9):326-32. Med Clin (Barc). 2008. PMID: 18817649 Spanish.
-
Cut-off points for defining asthma control in three versions of the Asthma Control Questionnaire.J Asthma. 2010 Oct;47(8):865-70. doi: 10.3109/02770903.2010.491149. J Asthma. 2010. PMID: 20846084
-
Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli.J Asthma. 1997;34(2):105-11. doi: 10.3109/02770909709075654. J Asthma. 1997. PMID: 9088296
-
Tools to assess (and achieve?) long-term asthma control.Respir Med. 2004 Oct;98 Suppl B:S16-21. doi: 10.1016/j.rmed.2004.07.011. Respir Med. 2004. PMID: 15481284 Review.
-
Correlation between objective measures of airway calibre and clinical symptoms in asthma: a systematic review of clinical studies.Respir Med. 2000 Aug;94(8):735-41. doi: 10.1053/rmed.2000.0814. Respir Med. 2000. PMID: 10955747 Review.
Cited by
-
Latent myofascial trigger points injection therapy for adult cough variant asthma: A randomized controlled trial.Front Med (Lausanne). 2023 Feb 23;10:937377. doi: 10.3389/fmed.2023.937377. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36910483 Free PMC article.
-
Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study.J Asthma Allergy. 2022 May 23;15:703-712. doi: 10.2147/JAA.S360260. eCollection 2022. J Asthma Allergy. 2022. PMID: 35651483 Free PMC article.
-
Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma.BMC Pulm Med. 2020 Apr 9;20(1):87. doi: 10.1186/s12890-020-1069-2. BMC Pulm Med. 2020. PMID: 32272921 Free PMC article.
-
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).J Asthma Allergy. 2020 Feb 17;13:115-126. doi: 10.2147/JAA.S240044. eCollection 2020. J Asthma Allergy. 2020. PMID: 32110060 Free PMC article.
-
Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.Int J Chron Obstruct Pulmon Dis. 2020 Feb 5;15:269-277. doi: 10.2147/COPD.S231004. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32103926 Free PMC article. Clinical Trial.
References
-
- Woolcock A, et al. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med. J. Aust. 1989;151:650–653. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
